The Effect of Phonophoresis in Subacromial Impingement Syndrome.
Phonophoresis Therapy in Subacromial Impingement Syndrome: Comparing of Pulsed Mode Ultrasound Phonophoresis and Continuous Mode Ultrasound Phonophoresis.
1 other identifier
interventional
88
1 country
1
Brief Summary
Subacromial impingement syndrome (SIS) is a dysfunction caused by an impingement of the rotator cuff tendon between the head of the humerus and the acromion as a result of changes in the subacromial space. The patients' symptoms, such as pain, limited joint mobility and reduced strength, may lead to a diagnosis of SIS. The conservative treatment of individuals with SIS is includes analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), steroid injections and physiotherapy. Ultrasound therapy is one of the common physiotherapy applications for SIS, but its effectiveness is controversial. Phonophoresis is a combination of ultrasound therapy and medical therapy. In phonophoresis, a medicine in gel form is used as a transmitter with ultrasound instead of the aquatic conductor gel. It was hypothesized that ultrasound waves favoring the penetration of an anti-inflammatory drug would lead to an improved response to the treatment of SIS. However, the effectiveness of ultrasound modes (pulsed or continuous) can be used in phonophoresis is debatable. The purpose of this study is to determine the effect of ultrasound therapy, pulsed mode ultrasound and continuous mode ultrasound phonophoresis in patients with SIS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
December 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2021
CompletedJuly 28, 2021
July 1, 2021
1.8 years
December 18, 2020
July 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Visual Analog Scale
The visual analog scale (VAS) is a pain rating scale first used by Hayes and Patterson in 1921. Scores are based on self-reported measures of symptoms that are recorded with a single handwritten mark placed at one point along the length of a 10-cm line that represents a continuum between the two ends of the scale-"no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10 cm).
Baseline, Change from baseline pain scores at three weeks, Change from baseline pain scores at three months
The Shortened version of Disability of the Arm, Shoulder, and Hand
Disability of the Arm, Shoulder, and Hand (DASH) was designed to describe disability experienced by patients with any musculoskeletal condition of the upper extremity and to monitor change in symptoms and upper limb function over time. The DASH questionnaire has been validated in patients with upper extremity musculoskeletal disorders such as rheumatoid arthritis and shoulder impingement syndrome. The Quick-DASH is a shortened version of the DASH
Baseline, Change from baseline shoulder pain and function scores at three weeks, Change from baseline shoulder pain and function at three months
Secondary Outcomes (1)
Nottingham Health Profile
Baseline, Change from baseline quality of life scores at three weeks, Change from baseline quality of life scores at three months
Study Arms (3)
pulsed mode phonophoresis group
EXPERIMENTALPhonophoresis therapy with pulsed mode ultrasound.
continuous mode phonophoresis group
EXPERIMENTALPhonophoresis therapy with continuous mode ultrasound.
sham group
SHAM COMPARATORSham ultrasound
Interventions
phonophoresis therapy with pulsed mode ultrasound, five days a week for three weeks
phonophoresis therapy with pulsed mode ultrasound, five days a week for three weeks
Eligibility Criteria
You may qualify if:
- to be diagnosed as shoulder impingement syndrome,
- shoulder pain for at least one month,
- VAS score over 40mm.
You may not qualify if:
- grade III supraspinatus tendon injury,
- major shoulder trauma,
- diabetes mellitus,
- hipotiroidizm,
- adhesive capsulitis,
- cardiac pacemaker
- physical therapy or local injection to the shoulder at last six month
- serious cervical pathologies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Volkan deniz
Ankara, 06560, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bayram Kelle, Assoc. Prof.
Cukurova University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- sham
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc
Study Record Dates
First Submitted
December 18, 2020
First Posted
December 21, 2020
Study Start
April 1, 2019
Primary Completion
January 15, 2021
Study Completion
January 30, 2021
Last Updated
July 28, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share